These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25582572)

  • 21. Myositis Autoantibodies: A Comparison of Results From the Oklahoma Medical Research Foundation Myositis Panel to the Euroimmun Research Line Blot.
    Mecoli CA; Albayda J; Tiniakou E; Paik JJ; Zahid U; Danoff SK; Casciola-Rosen L; Casal-Dominguez M; Pak K; Pinal-Fernandez I; Mammen AL; Christopher-Stine L
    Arthritis Rheumatol; 2020 Jan; 72(1):192-194. PubMed ID: 31430029
    [No Abstract]   [Full Text] [Related]  

  • 22. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC; Reed AM
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymyositis-dermatomyositis: a clinical review.
    Strauss KW; Gonzalez-Buritica H; Khamashta MA; Hughes GR
    Postgrad Med J; 1989 Jul; 65(765):437-43. PubMed ID: 2690042
    [No Abstract]   [Full Text] [Related]  

  • 24. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
    Mathiesen PR; Buchvald F; Nielsen KG; Herlin T; Friis T; Nielsen S
    Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humoral immunity in polymyositis and dermatomyositis.
    Targoff IN; Reichlin M
    Mt Sinai J Med; 1988 Nov; 55(6):487-93. PubMed ID: 3068537
    [No Abstract]   [Full Text] [Related]  

  • 26. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T; Imura Y; Nakashima R; Yoshifuji H
    Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Autoantibodies in collagen diseases].
    Meyer O
    Ann Med Interne (Paris); 1986; 137(8):666-78. PubMed ID: 2436515
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunoserological aspects of idiopathic inflammatory muscle disease.
    Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.
    Pachman LM; Khojah AM
    J Pediatr; 2018 Apr; 195():16-27. PubMed ID: 29576174
    [No Abstract]   [Full Text] [Related]  

  • 30. Western-blotting method for detecting antibodies against human muscle contractile proteins in myositis.
    Koga K; Abe S; Hashimoto H; Yamaguchi M
    J Immunol Methods; 1987 Dec; 105(1):15-21. PubMed ID: 3316405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the immunopathophysiology of the idiopathic inflammatory myopathies: not as simple as suspected.
    Hengstman GJ
    Curr Rheumatol Rep; 2007 Aug; 9(4):280-5. PubMed ID: 17688836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria.
    To F; Parker MJS; Ventín-Rodríguez C; Lilleker JB; Chinoy H
    Rheumatology (Oxford); 2019 Dec; 58(12):2331-2333. PubMed ID: 31382296
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
    Arad-Dann H; Isenberg DA; Shoenfeld Y; Offen D; Sperling J; Sperling R
    J Immunol; 1987 Apr; 138(8):2463-8. PubMed ID: 3494067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies.
    Mauhin W; Mariampillai K; Allenbach Y; Charuel JL; Musset L; Benveniste O
    Joint Bone Spine; 2018 May; 85(3):375-376. PubMed ID: 28435082
    [No Abstract]   [Full Text] [Related]  

  • 36. Autoantibodies against TIF-1-γ and CADM-140 in Spanish patients with clinically amyopathic dermatomyositis (CADM): clinical significance and diagnostic utility.
    Cuesta-Mateos C; Colom-Fernández B; Portero-Sainz I; Tejedor R; García-García C; Concha-Garzón MJ; De las Heras-Alonso ME; Martínez MA; Juarez C; Muñoz-Calleja C
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):482-9. PubMed ID: 25065441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory myopathies--a clinicopathologic study.
    Radhakrishnan VV; Nair MD; Kuruvilla A; Radhakrishnan K
    Indian J Pathol Microbiol; 1997 Jul; 40(3):315-20. PubMed ID: 9354000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic approaches in patients with inflammatory myopathies.
    Dalakas MC
    Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.